Journal of Multiple Sclerosis
ISSN - 2376-0389NLM - 101654564
Department of Pharmaceutics, Chalapathi Institute of Pharmaceutical Sciences, Acharya Nagarjuna University, India
Commentary
Impact of fingolimod on multiple sclerosis
Author(s): Gowthami Bainaboina*
The effectiveness of fingolimod on clinical and magnetic resonance imaging (MRI) outcomes in patients with multiple sclerosis (MS) has been well established in trials and, to a lesser extent, in the real world
.. View More»
DOI:
10.35248/2376-0389.21.8.238
